What's new in TB?

Anna Ralph, Paul Kelly, Victoria Krause

Research output: Contribution to journalArticlepeer-review


Australia has among the world’s lowest rates of tuberculosis (TB). However, it remains a leading global cause of morbidity and mortality. In Australia, TB remains more common in Indigenous than non-Indigenous Australians, and rates are rising among migrants, reflecting changing immigration patterns and rising rates in their homelands.

This article reviews recent developments in TB of relevance to Australian general practice and provides an update of advances in the diagnosis and management of TB, and the role of the general practitioners in co-managing people with TB.

First hand experience with imported multidrug resistant TB (MDR-TB) is increasing and is anticipated to rise in Australia. The reach of extensively drug resistant TB is also expanding. Although standard guidelines for management of drug susceptible TB remain unchanged, recent progress in the understanding, diagnosis and management of TB has occurred, driven by the need to respond to the challenges of MDR-TB and HIV-TB co-infection.
Original languageEnglish
Pages (from-to)578-585
Number of pages8
JournalAustralian Family Physician
Issue number8
Publication statusPublished - 2009


Dive into the research topics of 'What's new in TB?'. Together they form a unique fingerprint.

Cite this